PAX3 silencing inhibits prostate cancer progression through the suppression of the TGF‐β/Smad signaling axis
Authors:
- 16 July 2020
- journal article
- research article
- Published by Wiley in Cell Biology International
- Vol. 44 (10) , 2131-2139
Abstract
Multiple studies have confirmed the pro‐oncogenic effects of PAX3 in an array of cancers, but its role in prostate cancer (PCa) remains largely undefined. The aim of this study is to investigate the role of PAX3 in PCa. PAX3 expression was compared between PCa tumor tissue and nontumor tissues and PCa cell lines and normal prostate epithelial cells (PNT2) by western blot analysis and immunohistochemistry staining. MTT and immunofluorescence assays were used to detect PCa cell proliferation. Flow cytometry was used to evaluate cell apoptosis in PCa. Transwell assays were used for the determination of cell migration and PCa cell invasion. PAX3 expression was higher in PCa tissues and human PCa cell lines. Moreover, PAX3 silencing inhibited the proliferation, metastasis, and epithelial–mesenchymal transition (EMT) of PCa cells, and increased the rates of apoptosis. PAX3 silencing inhibited transforming growth factor‐β (TGF‐β)/Smad signaling in PCa cells. The effects of si‐PAX3 on the proliferation, apoptosis, metastasis, and EMT of PCa cells were alleviated by TGF‐β1 treatment. PAX3 silencing inhibits PCa progression through the inhibition of TGF‐β/Smad signaling. This reveals PAX3 as a novel biomarker and therapeutic target for future PCa treatments.Keywords
This publication has 23 references indexed in Scilit:
- Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinomaOncology Reports, 2016
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- Activation of PAX3-MET pathways due to miR-206 loss promotes gastric cancer metastasisCarcinogenesis, 2015
- A critical review of the epidemiology of Agent Orange/TCDD and prostate cancerEuropean Journal of Epidemiology, 2014
- PAX3 is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cellsBrain Research, 2013
- Hyper-expression of PAX2 in human metastatic prostate tumors and its role as a cancer promoter in an in vitro invasion modelThe Prostate, 2013
- GSK-3 Promotes Cell Survival, Growth, and PAX3 Levels in Human Melanoma CellsMolecular Cancer Research, 2012
- PAX Genes in Cancer; Friends or Foes?Frontiers in Genetics, 2012
- A PANorama of PAX genes in cancer and developmentNature Reviews Cancer, 2006
- EXPRESSION OF THE DEVELOPMENTAL AND ONCOGENIC PAX2 GENE IN HUMAN PROSTATE CANCERJournal of Urology, 2001